Literature DB >> 24723

Inhibition of mouse brain monoamine oxidase by (+)-amphetamine in vivo.

A L Green, M A el Hait.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 24723     DOI： 10.1111/j.2042-7158.1978.tb13223.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  14 in total

1.  Social bonding decreases the rewarding properties of amphetamine through a dopamine D1 receptor-mediated mechanism.

Authors:  Yan Liu; Kimberly A Young; J Thomas Curtis; Brandon J Aragona; Zuoxin Wang
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

Review 2.  Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.

Authors:  S R Jones; R R Gainetdinov; R M Wightman; M G Caron
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

3.  Monoamine oxidase inhibition by (+)-amphetamine in vivo [proceedings].

Authors:  D E Clarke; H H Miller; P A Shore
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

4.  "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.

Authors:  M T Martin-Iverson; N Yamada; A W By; B A Lodge
Journal:  J Psychiatry Neurosci       Date:  1991-12       Impact factor: 6.186

5.  3-Methoxytyramine: its suitability as an indicator of synaptic dopamine release.

Authors:  P C Waldmeier; J Lauber; W Blum; W J Richter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-01       Impact factor: 3.000

6.  Absence of platelet monamine oxidase inhibition during amitriptyline or zimelidine treatment.

Authors:  M A Reveley; V Glover; M Slander; A Coppen
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

Review 7.  Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

Authors:  Michael J Minzenberg
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

8.  Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine.

Authors:  Evgeny A Budygin; Mark S Brodie; Tatyana D Sotnikova; Yolanda Mateo; Carrie E John; Michel Cyr; Raul R Gainetdinov; Sara R Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

9.  (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.

Authors:  K Svensson; A M Johansson; T Magnusson; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-11       Impact factor: 3.000

10.  Facilitating effect of amphetamine on the response of rabbit aortic strips to adrenaline, dopamine and serotonin.

Authors:  B Silvestrini; M Palmery; F Basta; P Valeri
Journal:  J Neural Transm Gen Sect       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.